| UniProt ID | SSBP3_HUMAN | |
|---|---|---|
| UniProt AC | Q9BWW4 | |
| Protein Name | Single-stranded DNA-binding protein 3 | |
| Gene Name | SSBP3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 388 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | May be involved in transcription regulation of the alpha 2(I) collagen gene where it binds to the single-stranded polypyrimidine sequences in the promoter region.. | |
| Protein Sequence | MFAKGKGSAVPSDGQAREKLALYVYEYLLHVGAQKSAQTFLSEIRWEKNITLGEPPGFLHSWWCVFWDLYCAAPERRDTCEHSSEAKAFHDYSAAAAPSPVLGNIPPNDGMPGGPIPPGFFQGPPGSQPSPHAQPPPHNPSSMMGPHSQPFMSPRYAGGPRPPIRMGNQPPGGVPGTQPLLPNSMDPTRQQGHPNMGGSMQRMNPPRGMGPMGPGPQNYGSGMRPPPNSLGPAMPGINMGPGAGRPWPNPNSANSIPYSSSSPGTYVGPPGGGGPPGTPIMPSPADSTNSSDNIYTMINPVPPGGSRSNFPMGPGSDGPMGGMGGMEPHHMNGSLGSGDIDGLPKNSPNNISGISNPPGTPRDDGELGGNFLHSFQNDNYSPSMTMSV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MFAKGKGS -------CCCCCCCC | 7.13 | 22814378 | |
| 4 | Ubiquitination | ----MFAKGKGSAVP ----CCCCCCCCCCC | 50.30 | - | |
| 6 | Ubiquitination | --MFAKGKGSAVPSD --CCCCCCCCCCCCC | 49.32 | - | |
| 6 (in isoform 3) | Ubiquitination | - | 49.32 | 21906983 | |
| 6 (in isoform 2) | Ubiquitination | - | 49.32 | 21906983 | |
| 6 (in isoform 1) | Ubiquitination | - | 49.32 | 21906983 | |
| 8 | Phosphorylation | MFAKGKGSAVPSDGQ CCCCCCCCCCCCCCH | 29.58 | 29396449 | |
| 19 | Ubiquitination | SDGQAREKLALYVYE CCCHHHHHHHHHHHH | 33.24 | - | |
| 23 | Phosphorylation | AREKLALYVYEYLLH HHHHHHHHHHHHHHH | 8.72 | 18080319 | |
| 25 | Phosphorylation | EKLALYVYEYLLHVG HHHHHHHHHHHHHHC | 5.82 | 18080319 | |
| 36 | Phosphorylation | LHVGAQKSAQTFLSE HHHCCHHHHHHHHHH | 17.33 | 22210691 | |
| 42 | Phosphorylation | KSAQTFLSEIRWEKN HHHHHHHHHHHHHCC | 27.13 | 24719451 | |
| 128 (in isoform 2) | Methylation | - | 48.70 | - | |
| 155 | Asymmetric dimethylarginine | SQPFMSPRYAGGPRP CCCCCCCCCCCCCCC | 26.99 | - | |
| 155 | Methylation | SQPFMSPRYAGGPRP CCCCCCCCCCCCCCC | 26.99 | 24129315 | |
| 156 | Phosphorylation | QPFMSPRYAGGPRPP CCCCCCCCCCCCCCC | 17.00 | 22817900 | |
| 161 | Asymmetric dimethylarginine | PRYAGGPRPPIRMGN CCCCCCCCCCCCCCC | 53.56 | - | |
| 161 | Methylation | PRYAGGPRPPIRMGN CCCCCCCCCCCCCCC | 53.56 | 24129315 | |
| 165 | Asymmetric dimethylarginine | GGPRPPIRMGNQPPG CCCCCCCCCCCCCCC | 32.50 | - | |
| 165 | Methylation | GGPRPPIRMGNQPPG CCCCCCCCCCCCCCC | 32.50 | 24129315 | |
| 202 | Methylation | NMGGSMQRMNPPRGM CCCCCCCCCCCCCCC | 20.43 | 97795479 | |
| 265 | O-linked_Glycosylation | YSSSSPGTYVGPPGG CCCCCCCCCCCCCCC | 20.58 | 29485866 | |
| 316 | Phosphorylation | NFPMGPGSDGPMGGM CCCCCCCCCCCCCCC | 42.39 | 28348404 | |
| 320 (in isoform 2) | Phosphorylation | - | 9.91 | - | |
| 325 (in isoform 2) | Phosphorylation | - | 14.37 | - | |
| 327 (in isoform 3) | Phosphorylation | - | 44.77 | - | |
| 332 (in isoform 3) | Phosphorylation | - | 32.32 | - | |
| 333 (in isoform 2) | Phosphorylation | - | 19.37 | - | |
| 334 | Phosphorylation | EPHHMNGSLGSGDID CCCCCCCCCCCCCCC | 25.26 | 26074081 | |
| 337 | Phosphorylation | HMNGSLGSGDIDGLP CCCCCCCCCCCCCCC | 38.29 | 26074081 | |
| 340 (in isoform 3) | Phosphorylation | - | 5.30 | - | |
| 347 | Phosphorylation | IDGLPKNSPNNISGI CCCCCCCCCCCCCCC | 34.82 | 19664994 | |
| 352 | Phosphorylation | KNSPNNISGISNPPG CCCCCCCCCCCCCCC | 32.00 | 30266825 | |
| 354 (in isoform 2) | Phosphorylation | - | 2.62 | - | |
| 355 | Phosphorylation | PNNISGISNPPGTPR CCCCCCCCCCCCCCC | 46.97 | 30266825 | |
| 360 (in isoform 2) | Phosphorylation | - | 22.41 | - | |
| 360 | Phosphorylation | GISNPPGTPRDDGEL CCCCCCCCCCCCCCC | 22.41 | 22167270 | |
| 361 (in isoform 3) | Phosphorylation | - | 43.55 | - | |
| 367 (in isoform 3) | Phosphorylation | - | 15.10 | - | |
| 374 | Phosphorylation | LGGNFLHSFQNDNYS CCHHHHHHHCCCCCC | 30.58 | 21406692 | |
| 380 | Phosphorylation | HSFQNDNYSPSMTMS HHHCCCCCCCCCEEC | 25.48 | 20363803 | |
| 381 | Phosphorylation | SFQNDNYSPSMTMSV HHCCCCCCCCCEECC | 19.43 | 26055452 | |
| 383 | Phosphorylation | QNDNYSPSMTMSV-- CCCCCCCCCEECC-- | 22.42 | 23663014 | |
| 385 | Phosphorylation | DNYSPSMTMSV---- CCCCCCCEECC---- | 15.61 | 30177828 | |
| 387 | Phosphorylation | YSPSMTMSV------ CCCCCEECC------ | 18.60 | 26055452 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SSBP3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SSBP3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ANKE1_HUMAN | ANKEF1 | physical | 20211142 | |
| A4_HUMAN | APP | physical | 21832049 | |
| I36RA_HUMAN | IL36RN | physical | 25416956 | |
| TBC23_HUMAN | TBC1D23 | physical | 25416956 | |
| NXT2_HUMAN | NXT2 | physical | 25416956 | |
| LDB1_HUMAN | LDB1 | physical | 26186194 | |
| RRP44_HUMAN | DIS3 | physical | 26186194 | |
| LHX1_HUMAN | LHX1 | physical | 26186194 | |
| ISL2_HUMAN | ISL2 | physical | 26186194 | |
| ISL1_HUMAN | ISL1 | physical | 26186194 | |
| LMO4_HUMAN | LMO4 | physical | 26186194 | |
| ISL2_HUMAN | ISL2 | physical | 28514442 | |
| LDB1_HUMAN | LDB1 | physical | 28514442 | |
| ISL1_HUMAN | ISL1 | physical | 28514442 | |
| LMO4_HUMAN | LMO4 | physical | 28514442 | |
| RRP44_HUMAN | DIS3 | physical | 28514442 | |
| LHX1_HUMAN | LHX1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347; SER-352; THR-360;SER-381 AND SER-387, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347; SER-352 ANDTHR-360, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-381 AND SER-387, ANDMASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347 AND THR-360, ANDMASS SPECTROMETRY. | |